Panelists in this video:
• Dr Manoj Kumar Kashyap, Professor and Director, Research & Development, Parul University, Goa (MODERATOR)
• Dr Pradeep Kumar Vishwakarma, Associate Director – COE Manufacturing Science and Technology Respiratory, Cipla
• Dr Bhaskar Chauhan, Head R&D and Quality Management, Puniska Injectables
• Mr Sartaj Hanfi, Sr GM – Plant Head, Indoco Remedies
• Mr Vishwas J Desai, GM – Quality Assurance, Blue Cross Laboratories
• Mr Abhinay Ajgaonkar, DGM – Head of QA, Centaur Pharmaceuticals
• Ms Urmila Deepak Naik, AGM, FDC Limited Goa (Unit III)
Key Highlights:
[1] The real shift is from “passing audits” to building organisations that are always ready for scrutiny.
[2] Talent could become the next bottleneck for pharma quality. Technology is advancing faster than skills.
[3] The future of quality is increasingly data-led. Digital systems can turn quality data into action, not just documentation.
[4] To compete globally, Goa needs to own more of the pharma value chain—from R&D to technology transfer to manufacturing.
[5] Question the legacy. If the data supports a better way, pharma needs the confidence to challenge “how it has always been done.”
[6] The shop floor is the new classroom. Future-ready talent needs hands-on exposure to machines, technology and real manufacturing problems.
[7] Innovation needs a bridge between campus and industry. Collaboration should go beyond MOUs to creating real opportunities for research and problem-solving.